Front Desk: 469-391-0070
Phencyclidine Use Disorder: Causes, Symptoms & Treatment Options
Introduction
Phencyclidine (PCP) use disorder is a serious condition that develops when an individual repeatedly uses the hallucinogenic drug phencyclidine, commonly known as PCP or “angel dust.” Originally developed as an anesthetic in the 1950s, PCP was discontinued for medical use due to its severe side effects, including hallucinations, delusions, and violent behavior. Today, PCP is classified as a Schedule II controlled substance, meaning it has a high potential for abuse and poses a significant risk of psychological or physical dependence. This article provides a comprehensive overview of PCP use disorder, covering its risk factors, symptoms, diagnostic tests, and treatment options. We will also discuss steps patients can take at home to manage their symptoms.
Definition of Phencyclidine Use Disorder
Phencyclidine use disorder is characterized by the compulsive use of PCP despite harmful consequences. This article will explore its risk factors, symptoms, diagnostic tests, medications, procedures, and self-care strategies.
Description of Phencyclidine Use Disorder
Phencyclidine use disorder is a type of substance use disorder in which individuals develop a dependence on PCP, a powerful dissociative drug. PCP affects the brain by altering neurotransmitter activity, particularly glutamate, which plays a key role in perception, memory, and cognition. As a result, users may experience hallucinations, delusions, and a distorted sense of reality.
The progression of PCP use disorder can vary. Initially, individuals may use the drug recreationally for its euphoric and hallucinogenic effects. However, repeated use often leads to tolerance, requiring higher doses to achieve the same effects, which increases the risk of overdose and severe psychological symptoms such as paranoia and aggression. Chronic use can result in long-term cognitive impairments, memory problems, and emotional instability.
While PCP use is less common than substances like alcohol or opioids, it remains a significant public health concern. According to the National Institute on Drug Abuse (NIDA), approximately 1.3% of people aged 12 or older in the United States have used PCP at least once. PCP use is more prevalent in high-risk populations, including individuals with a history of trauma or mental illness.
Risk Factors for Developing Phencyclidine Use Disorder
Lifestyle Risk Factors
Certain lifestyle factors increase the likelihood of developing PCP use disorder. One significant factor is recreational drug use, particularly in social settings where PCP is available. Peer pressure and the desire to experiment with new substances can lead individuals to try PCP, especially in environments where drug use is normalized. Additionally, individuals who use other substances, such as alcohol, marijuana, or cocaine, may be more likely to try PCP as part of polysubstance use.
Stressful life events, such as the loss of a loved one, financial difficulties, or relationship problems, can also contribute to substance use disorders. Some individuals may turn to PCP to cope with emotional pain or to escape reality. Living in areas with high drug use or limited access to mental health services can further increase the risk of developing a PCP use disorder.
Medical Risk Factors
Individuals with certain medical conditions may be at higher risk for developing PCP use disorder. Mental health disorders like depression, anxiety, bipolar disorder, and schizophrenia are strongly associated with substance use disorders. People with these conditions may use PCP to self-medicate, seeking temporary relief from their symptoms. However, PCP use can worsen mental health conditions over time, creating a dangerous cycle of substance use and psychological distress.
Additionally, individuals with a history of trauma, such as childhood abuse or post-traumatic stress disorder (PTSD), may be more vulnerable to developing substance use disorders, including PCP use disorder. Chronic pain conditions and other physical health issues requiring long-term management may also increase the risk of substance use as individuals seek alternative methods of pain relief.
Genetic and Age-Related Risk Factors
Genetics can influence the development of substance use disorders, including PCP use disorder. Research shows that individuals with a family history of substance use disorders are more likely to develop similar conditions. This genetic predisposition may be due to inherited traits that affect how the brain responds to drugs, making some individuals more susceptible to addiction.
Age is another important factor. Adolescents and young adults are at higher risk for experimenting with drugs, including PCP, due to developmental factors such as impulsivity, peer pressure, and a desire for new experiences. The brain continues to develop into the mid-20s, and drug use during this critical period can have lasting effects on brain function, increasing the likelihood of developing a substance use disorder.
Clinical Manifestations of Phencyclidine Use Disorder
Dissociation
Dissociation occurs in approximately 50-75% of patients with PCP use disorder. Dissociation refers to a feeling of being detached from one’s body or surroundings. This symptom is common during both acute intoxication and in chronic users, as PCP disrupts the normal functioning of neurotransmitters in the brain, particularly glutamate. Glutamate is critical for memory, learning, and perception, and its disruption can lead to a sense of disconnection from reality. Patients may describe feeling as though they are watching themselves from outside their body or that the world around them is not real. This can be a frightening experience and is often a key reason why individuals seek medical help.
Hallucinations
Hallucinations are experienced by 30-50% of individuals with PCP use disorder. These can include visual, auditory, or tactile hallucinations, where the person sees, hears, or feels things that are not present. PCP alters the brain’s perception pathways, particularly in the areas responsible for sensory processing. These hallucinations can range from mild distortions to vivid, terrifying experiences, especially at higher doses of the drug. Hallucinations are more common during acute intoxication but can also occur in chronic users, especially those with long-term exposure to the drug.
Agitation
Agitation is observed in 40-60% of PCP users, particularly during the acute phase of intoxication. PCP’s effects on the brain’s neurotransmitter systems, especially dopamine, can lead to increased restlessness, irritability, and aggressive behavior. These symptoms can escalate quickly, making the individual unpredictable and, in some cases, dangerous to themselves or others. Agitation may also be accompanied by confusion or paranoia, further complicating the clinical picture. It is important for healthcare providers to manage agitation carefully to prevent harm.
Paranoia
Paranoia is present in 20-40% of patients with PCP use disorder. This symptom involves irrational fears or beliefs that others are trying to harm the individual. PCP’s disruption of normal brain function, particularly in the dopamine pathways, can lead to heightened suspicion and mistrust. Paranoia can be particularly dangerous as it may cause the individual to act defensively or aggressively, believing they are in danger. This symptom is more common in chronic users but can also occur during acute intoxication.
Confusion
Confusion occurs in 30-50% of individuals using PCP. This symptom is characterized by disorganized thinking, difficulty concentrating, and an inability to make sense of one’s surroundings. PCP interferes with the brain’s ability to process information, leading to cognitive impairment. Confusion is often seen during acute intoxication but can also persist in chronic users, especially those who have used the drug for an extended period. In severe cases, confusion can lead to dangerous situations, such as wandering into traffic or engaging in risky behaviors without understanding the consequences.
Impaired Motor Function
Impaired motor function is seen in 50-70% of PCP users. This includes symptoms such as unsteady gait, poor coordination, and difficulty with fine motor tasks. PCP affects the brain’s motor control centers, leading to a loss of balance and coordination. These effects are dose-dependent, meaning that higher doses of PCP are more likely to cause significant motor impairment. In some cases, individuals may appear to be intoxicated with alcohol due to their unsteady movements and slurred speech. This symptom can be dangerous, as it increases the risk of falls and accidents.
Anxiety
Anxiety is experienced by 20-40% of individuals with PCP use disorder. This can range from mild unease to full-blown panic attacks, depending on the dose and frequency of use. PCP’s effects on the brain’s neurotransmitters, particularly serotonin and norepinephrine, can lead to heightened anxiety and fear. Anxiety is more common during withdrawal or when the drug’s effects are wearing off. Chronic users may experience ongoing anxiety even when not using the drug, as PCP can cause long-term changes in brain chemistry.
Depression
Depression affects 15-30% of individuals with PCP use disorder, particularly those who have used the drug for a long time. This symptom is likely due to the drug’s disruption of neurotransmitter systems, particularly serotonin and dopamine, which are involved in mood regulation. Depression can occur during withdrawal or as a long-term consequence of chronic use. Individuals may feel hopeless, lose interest in activities they once enjoyed, or experience changes in sleep and appetite. In severe cases, depression can lead to suicidal thoughts or behaviors.
Psychosis
Psychosis is seen in 10-20% of individuals with PCP use disorder, particularly those who have used the drug for an extended period. Psychosis involves a loss of contact with reality, including delusions and hallucinations. PCP’s effects on the brain’s glutamate and dopamine systems can lead to a breakdown in normal thought processes, resulting in psychotic symptoms. These symptoms can be temporary, occurring during acute intoxication, or they can persist in chronic users, leading to a condition known as PCP-induced psychotic disorder. Psychosis is a serious complication that requires immediate medical attention.
Delusions
Delusions are experienced by 10-20% of individuals with PCP use disorder. These are false beliefs that are not based in reality, such as believing that one has special powers or that others are plotting against them. Delusions are often associated with psychosis and can be dangerous if they lead the individual to act on their false beliefs. For example, a person may believe they can fly and attempt to jump from a high place. Delusions are more common in chronic users and can persist even after the drug has been cleared from the body.
html
Treatment Options for Phencyclidine (PCP) Use Disorder
Medications for Managing PCP Use Disorder
Naltrexone
Definition: Naltrexone works by blocking opioid receptors in the brain, which helps reduce cravings and diminishes the euphoric effects of substances like alcohol and PCP.
How and When It’s Used: Naltrexone is used to treat various substance use disorders, including PCP use disorder. It is typically part of a broader treatment plan that includes counseling and behavioral therapy. While not the first choice for treating PCP use disorder, it can be beneficial when cravings are a significant obstacle to recovery.
Expected Outcomes: Patients taking Naltrexone may experience fewer cravings and a reduced risk of relapse, with noticeable improvements often occurring within the first few weeks.
Acamprosate
Definition: Acamprosate helps individuals maintain abstinence from substances like alcohol and PCP by stabilizing brain activity that has been disrupted by long-term substance use.
How and When It’s Used: Acamprosate is typically prescribed after detoxification from PCP. It helps balance chemical imbalances in the brain that contribute to cravings and withdrawal symptoms. It is often used in combination with therapy and support groups.
Expected Outcomes: Patients may experience fewer cravings and a lower likelihood of relapse. The effects are gradual and may take several weeks to become apparent.
Disulfiram
Definition: Disulfiram causes an unpleasant reaction when alcohol is consumed, discouraging individuals from drinking. While primarily used for alcohol use disorder, it may be prescribed off-label for PCP use disorder.
How and When It’s Used: Disulfiram is generally used in cases where both alcohol and PCP use disorders are present. It is not a first-line treatment for PCP use but can be helpful for individuals struggling with both substances. It is typically used alongside behavioral therapy and other medications.
Expected Outcomes: The primary goal is to deter alcohol consumption, allowing patients to focus on their recovery from PCP use. The effects are immediate upon alcohol consumption, but long-term success depends on adherence to the treatment plan.
Topiramate
Definition: Topiramate is an anticonvulsant that helps reduce cravings and the pleasurable effects of substances like PCP.
How and When It’s Used: Topiramate is often used off-label for treating substance use disorders, including PCP use disorder. It is typically prescribed when other medications have not effectively reduced cravings. It works by modulating neurotransmitters to decrease the reinforcing effects of drugs.
Expected Outcomes: Patients may experience reduced cravings and an improved ability to maintain abstinence, with effects usually becoming noticeable within a few weeks.
Gabapentin
Definition: Gabapentin is commonly used to treat nerve pain and seizures but has also been shown to reduce cravings and withdrawal symptoms in substance use disorders.
How and When It’s Used: Gabapentin is often prescribed for patients experiencing anxiety or insomnia related to PCP withdrawal. It is typically used in combination with other medications and therapies. While not a first-line treatment, it can be helpful for individuals with co-occurring mental health conditions.
Expected Outcomes: Patients may experience relief from anxiety and insomnia, which can improve their ability to engage in recovery. The effects are usually noticeable within a few days.
Baclofen
Definition: Baclofen is a muscle relaxant that helps reduce cravings and withdrawal symptoms in individuals with substance use disorders, including PCP use disorder.
How and When It’s Used: Baclofen is typically prescribed for patients experiencing significant muscle tension or spasms during PCP withdrawal. It is often used in conjunction with other treatments, such as behavioral therapy. Baclofen is not a first-line treatment but may be considered in more severe cases of withdrawal.
Expected Outcomes: Patients may experience relief from physical withdrawal symptoms, such as muscle tension, making the recovery process more comfortable. The effects are usually noticeable within a few days.
Ondansetron
Definition: Ondansetron is an anti-nausea medication that has also been found to reduce cravings in individuals with substance use disorders, including PCP use disorder.
How and When It’s Used: Ondansetron is typically prescribed for patients experiencing nausea or vomiting during PCP withdrawal. It is often used in combination with other medications and therapies. While not a first-line treatment, it can help manage specific withdrawal symptoms.
Expected Outcomes: Patients may experience relief from nausea and vomiting, making the withdrawal process more tolerable. The effects are usually immediate after taking the medication.
Mirtazapine
Definition: Mirtazapine is an antidepressant that is sometimes used to treat substance use disorders by reducing anxiety, depression, and cravings.
How and When It’s Used: Mirtazapine is often prescribed for patients with co-occurring mental health conditions, such as depression or anxiety, which may worsen PCP use disorder. It is typically used alongside other treatments, such as therapy and support groups. Mirtazapine is not a first-line treatment but may be helpful for individuals with significant mental health symptoms.
Expected Outcomes: Patients may experience improved mood and reduced cravings, supporting their overall recovery. The effects are usually noticeable within a few weeks.
Clonidine
Definition: Clonidine is commonly used to treat high blood pressure but has also been found to reduce withdrawal symptoms in individuals with substance use disorders.
How and When It’s Used: Clonidine is often prescribed for patients experiencing symptoms such as anxiety, agitation, or high blood pressure during PCP withdrawal. It is typically used in combination with other medications and therapies. While not a first-line treatment, it can help manage specific withdrawal symptoms.
Expected Outcomes: Patients may experience relief from withdrawal symptoms, making the recovery process more comfortable. The effects are usually noticeable within a few days.
Improving Phencyclidine Use Disorder and Seeking Medical Help
In addition to medical treatments, several home remedies and lifestyle changes can support recovery from PCP use disorder. Staying hydrated is essential, as it helps the body flush out toxins and maintain overall health. A balanced diet rich in nutrients can improve energy levels and support brain function, which is often impaired by substance use. Regular exercise can reduce stress and improve mood, while mindfulness practices like meditation can help individuals stay grounded and manage cravings. Support groups offer a sense of community and accountability, which can be invaluable during recovery. Journaling can also be a helpful tool for processing emotions and tracking progress. Avoiding triggers, such as places or people associated with drug use, is crucial for preventing relapse. Establishing a routine provides structure and stability, while stress management techniques like deep breathing or yoga can help individuals cope with the challenges of recovery.
Telemedicine offers a convenient and accessible way to seek help for PCP use disorder. Through virtual appointments, patients can receive medical advice, prescriptions, and referrals to specialists without leaving their homes. This option is especially helpful for individuals who may feel stigmatized or uncomfortable seeking in-person care. Early intervention is key to improving outcomes, so if you or a loved one is struggling with PCP use, consider reaching out to a healthcare provider through telemedicine.
Living with Phencyclidine Use Disorder: Tips for Better Quality of Life
Living with PCP use disorder can be challenging, but there are steps you can take to improve your quality of life. Staying connected with a support system, whether through friends, family, or support groups, is crucial. Engaging in activities that bring you joy and fulfillment can help you rebuild your life after substance use. Developing healthy coping mechanisms, such as exercise, meditation, or creative outlets, can provide alternatives to drug use. It’s also important to be patient with yourself during the recovery process—set realistic goals and celebrate small victories along the way.
Conclusion
Phencyclidine use disorder is a serious condition that requires comprehensive treatment, including medications, therapy, and lifestyle changes. Early diagnosis and intervention can significantly improve outcomes and reduce the risk of long-term complications. If you or a loved one is struggling with PCP use, don’t hesitate to seek help. Our telemedicine practice offers a convenient and confidential way to access the care you need. Reach out today to schedule an appointment and take the first step toward recovery.
